|
2022
|
Invention
|
Rotomeric isomers of 4-alkyl-5-heteroaryl-3h-1,2-dithiole-3-thiones.
This disclosure provides, a... |
|
2021
|
Invention
|
Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1,2-dithiole-3-thione, taste-modified formulations, ... |
|
|
Invention
|
Methods of treating viral infections with formulated compositions comprising 4-methyl-5-(pyrazin-... |
|
|
Invention
|
Methods for preparing oltipraz.
The invention provides improved methods of synthesizing oltipraz... |
|
|
Invention
|
Rotomeric isomers of 4-alkyl-5-heteroaryl-3h-1,2-dithiole-3-thiones. This disclosure provides, am... |
|
2020
|
Invention
|
Combination compositions and therapies comprising 4-methyl-5-(pyrazin-2-yl)-3h-1,2-dithiole-3-thi... |
|
|
Invention
|
Methods for preparing oltipraz. The invention provides improved methods of synthesizing oltipraz,... |
|
2019
|
Invention
|
Rotomeric isomers of 4-alkyl-5-heteroaryl-3h-1,2- dithiole-3-thiones. This disclosure provides, a... |
|
|
Invention
|
Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1,2-dithiole-3-thione, and methods of making and usi... |
|
|
Invention
|
Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-l,2-dithiole-3-thione, taste-modified formulations, ... |
|
2017
|
Invention
|
Compositions and methods for preventing and treating mucositis and weight loss.
Pharmaceutical c... |
|
|
Invention
|
Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1.2-dithiole-3-thione, taste-modified formulations, ... |
|
|
Invention
|
Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1, 2-dithiole-3-thione, and methods of making and us... |
|
2016
|
Invention
|
Honokiol and magnolol formulations with increased stability and improved uptake, and methods of u... |
|
2008
|
Invention
|
Compositions and methods for preventing and treating mucositis and weight loss. A method for prop... |
